期刊文献+

红皮病型银屑病伴发代谢相关性疾病的情况分析 被引量:7

Analyses on Metabolic-related Diseases in Patients with Erythrodermic Psoriasis
下载PDF
导出
摘要 目的分析红皮病型银屑病患者伴发代谢相关疾病(MD)的情况。方法对1995年1月-2010年3月在北京大学第三医院皮肤科住院的53例红皮病型银屑病患者伴发代谢相关疾病的临床资料进行回顾性分析,并与同期住院且年龄匹配的62例斑块状银屑病和60例急性荨麻疹患者(对照组)伴发代谢相关性疾病的情况作比较。结果红皮病型银屑病伴发MD、高脂血症(HLP)、腹型肥胖(AO)、代谢综合征(MS)及高尿酸血症(HUA)几率均显著高于对照组;斑块状银屑病伴发MD、高血压(HT)、HLP、AO、MS及HUA也显著高于对照组;男性红皮病型银屑病患者伴发HUA的几率高于对照组及斑块状银屑病组的男性患者,以上差异均有统计学意义(P均<0.05)。结论红皮病型银屑病与斑块状银屑病常伴发HLP、AO、MS及HUA等代谢相关疾病,男性红皮病型银屑病较男性斑块状银屑病更易伴发HUA。尿酸代谢紊乱是否与红皮病型银屑病发病相关还需要进一步研究。 Objective To study the prevalence of metabolic-related diseases in patients with erythrodermic psoriasis. Methods Metabolic-related diseases in 53 patients hospitalized in Peking University, the Third Hospital from Jan 1995 to Mar 2010 were studied, and compared with 62 age matched patients with plaque psoriasis, 60 age matched patients with acute urticaria (control) hospitalized in the same period. Results The eryth rodermic psoriasis patients had a higher prevalence of metabolic diseases ( MD), hyperlipidemia ( HLP), abdominal obesity(AO) ,metabolic syndrome(MS) and hyperuricemia(HUA) ( all P 〈 0.05 ). Patients with plaque psoriasis also had more hypertension (HT), MD, HLP, AO, MS and HUA than that of control group (all P 〈 0.05 ). A higher prevalence of HUA was found in male patients with erythrodermic psoriasis( all P 〈 0.05). Conclusion Metabolic-related diseases are Common in patients with erythrodermic psoriasis and plaque psoriasis. Male patients with erythrodermic psoriasis had a higher prevalence of HUA than patients with plaque psoriasis, the significance of HUA should be studied further.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2012年第10期894-895,899,共3页 The Chinese Journal of Dermatovenereology
基金 教育部高等学校青年骨干教师国内访问学者培训项目(2009.9-2010.7)
关键词 银屑病 红皮病型 代谢相关疾病 Psoriasis, Erythrodermic Metabolic-related diseases
  • 相关文献

参考文献18

  • 1Davidovici BB, Sattar N, Jorg PC, et al. Psorisis and systemic inflamma- tory diseases:potential mechanistic hnks between skin disease and co- morbid conditions [ J ]. J Invest dermatol. 2010,130 (7) : 1785 - 1796.
  • 2Kim N ,Thrash B,Menter A. Comorbidities in psoriasis patients[ J]. Se- min Cutan Med Surg. 2010,29( 1 ) :10 - 15.
  • 3Alsufyani MA, Golant AK, Lebwohl M. Psoriasis and the metabolic syn- drome[ J 1. Dermatol Ther,2010,23 ( 2 ) : 137 - 14-3.
  • 4赵辨.临床皮肤学[M].3版.南京:江苏科学技术出版社,2010:1008-1025.
  • 5程灏珠.实用内科学[M].13版.北京:人民卫生出版,2009:1018-2772.
  • 6纪立农.国际糖尿病联盟代谢综合征全球共识定义解读[J].中华糖尿病杂志(1006-6187),2005,13(3):175-177. 被引量:88
  • 7Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [ J ]. Circulation, 2005,112 (17) :2735 - 2752.
  • 8李葳,江倔,夏国光,张会英,王辅仁.脂肪肝高脂血症的年龄性别因素与胰岛素抵抗的关系探讨[J].中国全科医学,2000,3(5):355-356. 被引量:25
  • 9Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrom in patients with psoriasis : a hospital-based case-control study [J]. Br Dermatol, 2007, 157 ( 1 ) : 6.
  • 10程娟,杨雪琴,张丽,刘芳,惠让松,魏利召.银屑病患者伴发代谢综合征的临床特点[J].解放军医学杂志,2009,34(5):622-624. 被引量:15

二级参考文献23

共引文献126

同被引文献42

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部